Differential neuroendocrine responses to the 5-ht agonist m-chlorophenylpiperazine in fawn-hooded rats relative to wistar and sprague-dawley rats

Neuroendocrinology

Volumn 48, Issue 4, 1988, Pages 401-406

  Aulakh, Charanjit S ^a   Wozniak, Krystyna M ^a   Hill, James L ^a   Devane, C L ^b   Tolliver, Teresa J ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Corticosterone; Fawn Hooded rats; M Chlorophenylpiperazine; Prolactin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CORTICOSTERONE; PROLACTIN;

ANIMAL EXPERIMENT; CONTROLLED STUDY; ETHNIC OR RACIAL ASPECTS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN CHEMISTRY; COMPARATIVE STUDY; CORTICOSTERONE; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; MALE; NEUROSECRETORY SYSTEMS; PIPERAZINES; PROLACTIN; RATS; RATS, INBRED STRAINS; SEROTONIN;

EID: 0023706938     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000125041     Document Type: Article

References (34)

1. Aloi, J.A.; Insel, T.R.: Mueller, E.A.: Murphy, D.L.: Neuroen-docrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sci. 34: 1325-1331 (1984).
2. Arora, R.C.: Tong, C.; Jackman, H.: Stoff, D.: Meltzer, H.Y.: Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-Hooded and Sprague-Dawley rats. Life Sci. 33:437-442 (1983).
3. Asarch, K.B.: Ransom, R.W.: Shih, J.C.: 5-HTIa, and 5-HTIb, selectivity of two phenylpiperazine derivatives: Evidence for 5-HTIbhererogeneity. Life Sci. 36:1265-1273 (1985).
4. Briley, M.S.: Raisman, R.: Langer, S.Z.: Human platelets possess high affinity binding sites for3H-imipramine. Eur. J. Pharmacol. 58:347-348 (1979).
5. Buckingham, J.C.: Hodges, J.R.: Hypothalamic receptors influencing the secretion of corticotropin releasing hormone in the rat. J. Physiol. 290:421-431 (1979).
6. Clemens, J.A.; Roush, M.E.: Fuller, R.W.: Evidence that serotonin neurons stimulate secretion of prolactin releasing factor. Life Sci. 22:2209-2214(1978).
7. Curzon, G.: Dourish, C.T.: Kennett, G.A.: 5-HTIBagonists cause anorexia at post-synaptic receptors. Br. J. Pharmacol. 90: 91 P (1987).
8. Dumbrille-Ross, A.; Tang, S.W.: Absence of high affinity3H-imipramine binding in platelets and cerebral cortex of Fawn-Hooded rats. Eur. J. Pharmacol. 72:137-138 (1981).
9. Fuller, R.W.: Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology 32: 118-127 (1981).
10. Fuller, R.W.; Snoddy, H.D.: Mason, N.R.: Owens, J.E.: Disposition and pharmacological effects of m-chlorophenylpi-perazine in rats. Neuropharmacology 20:155-162 (1981).
11. Gudelsky, G.A.; Koenig, J.I.: Meltzer, H.Y.: Altered responses to serotonergic agents in Fawn-Hooded rats. Pharmacol. Biochem. Behav. 22:489-492 (1985).
12. Hamon, M.; Cossery, J.M.: Spampinato, U.: Gozlan, H.: Are there selective ligands for 5-HTIAand 5-HTIBreceptor binding sites in brain? Trends pharmac. Sci. 7:336-338 (1986).
13. Ieni, J.R.; Tobach, E.; Zukin, S.R.: Barr, G.A.: Van Praag, H.M.: Multiple3H-imipramine binding sites in brains of male and female Fawn-Hooded and Long-Evans rats. Eur. J. Pharmacol.112:261-264 (1985).
14. Invernizzi, R.: Cotecchia, S.: Deblasi, A.; Mennini, T.: Pataccini, R.: Samanin, R.: Effect of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochem. int. 3:239-244(1981).
15. Joseph, M.H.: Brain tryptophan metabolism on the 5-hydroxy-tryptamine and kynurenine pathways in a strain of rats with a deficiency in platelet 5-HT. Br. J. Pharmacol. 63: 529-533 (1978).
16. Koenig, J.I.: Gudelsky, G.A.; Meltzer, H.Y.: Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur. J. Pharmacol. 137: 1-8 (1987).
17. Lamberts, S.W.J.: Macleod, R.M.: The interaction of serotonergic and dopaminergic systems on prolactin secretion in the rat. Endocrinology 103:287-295 (1978).
18. Mefford, I. N.: Application of high performance liquid chroma-tography with electrochemical detection to neurochemical analysis: Measurement of catecholamines, serotonin and metabolites in rat brain. J. Neurosci. Methods 3:207-224 (1981).
19. Meltzer, H.Y.: Farg, V.S.; Paul, S.M.; Kaluskar, R.: Effect of quipazine on rat plasma prolactin levels. Life Sci. 19: 1073-1078(1976).
20. Meyers, K.M.: Hopkins, G.; Holmsen, H.: Benson, L.: Prieur, D. J.: Ultrastructure of resting and activated storage pool deficient platelets from animals with the Chediak-Higashi syndrome. Am. J. Path. 108:364-377 (1982).
21. Miller, R.L.; Devane, C.L.: Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high performance liquid chromatography. J. Chromatogr. 374:388-393 (1986).
22. Mueller, E.A.: Murphy, D.L.: Sunderland, T.: Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388-391 (1986).
23. Murray, T.F.: Debarrows, B.R.: Prieur, D.J.; Meyers, K.M.:3H-imipramine binding sites in Fawn-Hooded rats. Neuropharmacology 22:781-784 (1983).
24. Neill, J.D.: Reichert, L.E.: Development of a radioimmunoassay for rat prolactin and evaluation of the NIAMD rat prolactin radioimmunoassay. Endocrinology 88:548-555 (1971).
25. Peroutka, S.J.: Selective labeling of 5-HTIAand 5-HTIBbinding sites in bovine brain. Brain Res. 344:167-171 (1985).
26. Pettibone, D.J.: Williams, M.: Serotonin-releasing effects of substituted piperazines in vitro. Biochem. Pharmac. 33: 1531-1535(1984).
27. Quattrone, A.: Schettini, G.: Annunziato, L.: Direnzo, G.: Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. Eur. J. Pharmacol. 76:9-13 (1981).
28. Raymond, S.L.; Dodds, W.J.: Characteristics of the Fawn-Hooded rat as a model for hemostatic studies. Thromb. Diath. haemorrh. 33:361-369 (1975).
29. Sills, M.A.: Wolfe, B.B.: Frazer, A.: Determination of selective and nonselective compounds for the 5-HTIAand 5-HTIBreceptor subtypes in rat frontal cortex. J. Pharmac. exp. Ther. 231: 480-487 (1984).
30. Tobach, E.; DeSantis, J.L.; Zucker, M.B.: Platelet storage pool disease in hybrid rats: F1Fawn-Flooded rats derived from crosses with their putative ancestors (Rattus norvegicus). J. Hered. 75:15-18(1984).
31. Todd, R.D.: Ciaranello, R.D.: Multiple high affinity [3H]-se-rotonin binding sites in human frontal cortex. Brain Res. 400: 248-258(1987).
32. Underwood, R.M.; Williams, G.H.: The simultaneous measurement of aldosterone, cortisol and corticosterone in human peripheral plasma by displacement analysis. J. Lab. clin. Med. 79:848-862(1972).
33. Van de Kar, L.D.: Lorens, S.A.; Urban, J.H.: Kunimoto, K.: Bethea, C.L.: Comparison of the effects of serotonin (5-HTIA, andIB) agonists and 5-HT2antagonist on renin, corticosterone and prolactin secretion. Fed. Proc. 46:966 (1987).
34. Wang, P.: Aulakh C.S.; Hill, J.L.: Murphy, D.L.: Fawn-Hooded rats are subsensitive to the food intake suppressant ef-fects of 5-HT agonists. Pychopharmacology 94:558-562(1988).